Prolonged adrenal insufficiency after high-dose glucocorticoid in infants with leukemia

Pediatr Hematol Oncol. 2018 Aug-Sep;35(5-6):355-361. doi: 10.1080/08880018.2018.1539148. Epub 2018 Nov 20.

Abstract

Although outcomes for infant leukemia have improved recently, transient adrenal insufficiency is commonly observed during treatment, especially after glucocorticoid administration. We identified three infants with acute leukemia who suffered from prolonged adrenal insufficiency requiring long-term (from 15 to 66 months) hydrocortisone replacement. All infants showed life-threatening symptoms associated with adrenal crisis after viral infections or other stress. Severe and prolonged damage of hypothalamo-pituitary-adrenal (HPA) axis is likely to occur in early infants with leukemia, therefore routine tolerance testing to evaluate HPA axis and hydrocortisone replacement therapy are recommended for infants with leukemia to avoid life-threatening complications caused by adrenal crisis.

Keywords: Adrenal insufficiency; glucocorticoid; hypothalamic-pituitary-adrenal axis; infant leukemia.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adrenal Insufficiency* / chemically induced
  • Adrenal Insufficiency* / metabolism
  • Adrenal Insufficiency* / pathology
  • Adrenal Insufficiency* / therapy
  • Child, Preschool
  • Female
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / adverse effects*
  • Humans
  • Hypothalamo-Hypophyseal System / metabolism
  • Hypothalamo-Hypophyseal System / pathology
  • Infant, Newborn
  • Leukemia / drug therapy*
  • Leukemia / metabolism
  • Leukemia / pathology
  • Male
  • Pituitary-Adrenal System / metabolism
  • Pituitary-Adrenal System / pathology
  • Time Factors

Substances

  • Glucocorticoids